LEADING PHARMACEUTICAL COMPANIES USE ENSURE'S INNOVATIVE SECURITY TO PROTECT INTELLECTUAL PROPERTY, MEET INFORMATION SECURITY REGULATIONS

Ensure's Award-Winning XyLoc™ Security Solution Helps Companies Meet FDA Regulations for Securing Electronic Records and Protecting Integrity of Digital Signatures

Ann Arbor, Mich., September 23, 2002— Ensure Technologies, the leader in intelligent digital information security solutions, today announced that several leading pharmaceutical companies have selected Ensure's award-winning XyLoc™ security solution to help meet Food and Drug Administration (FDA) regulations for the protection of electronic information. Current FDA regulations require pharmaceutical companies to implement procedures to ensure the authenticity and integrity of electronic records, including limiting computer access to authorized individuals and keeping audit trails of computer activity. Banner Pharmacaps, Sanofi-Synthelabo and Schering-Plough are among the pharmaceutical companies using XyLoc's convenient and continuous security to help meet these requirements.

Pharmaceutical companies using XyLoc also have more control over electronic signatures, another FDA requirement. Electronic signatures provide an additional way to identify users, but a window of vulnerability exists anytime a computer is left unattended, even for a minute. XyLoc provides two-factor authentication of users, with the added safeguard of securing access to computer the moment authorized users step away.

"The drug approval process is a long and arduous one that should not be complicated with matters of information security," said George Brostoff, president of Ensure. "The FDA is understandably concerned with the authenticity of trial data and full-time protection of this information. XyLoc gives pharmaceutical companies the assurance that only authorized users have access to information systems, and provides an audit trail to prove it."

XyLoc: Protecting Pharmaceutical Companies

XyLoc is an award-winning security product that provides continuous authorization of employees in a manner that is convenient for users. At pharmaceutical companies protected by XyLoc, users wear unique XyLoc KeyCards (that can double as their ID badge) that communicate securely with proximity detection hardware and sophisticated software residing on each workstation. A computer is unlocked only after XyLoc has identified and authenticated a user.

Authentication can be as easy as walking up to the computer, or as robust as requiring users to input their name and password in addition to possessing the KeyCard. Users need to remember only one password, and with XyLoc's Single Sign On functionality all of their applications will automatically appear each time they approach a workstation. However, as soon as a user walks away from the computer, XyLoc secures the PC and the applications until the user returns or another authorized user approaches.

About Ensure Technologies

Headquartered in Ann Arbor, Michigan, Ensure Technologies (www.ensuretech.com) is the leader in intelligent digital information security solutions designed to protect an organization's intellectual property and physical computing assets from internal security breaches - conveniently, automatically and transparently. Ensure's XyLoc products apply the innovative, patented technologies of full-time access control and proximity-based authentication to guard corporate data, and asset tracking to monitor and protect computing hardware throughout the enterprise from desktops to mobile PCs. XyLoc delivers security with convenience and personalization at leading organizations in healthcare, financial services, government, manufacturing, and law throughout the world. XyLoc has won the TEPR Award for Best Healthcare Security Solution at the TEPR (Towards an Electronic Patient Record) Conference for two years running.

# # #

Back to News Releases

 
 
   
       
Ensure Technologies
(734) 668-8800 (voice) (734) 668-1242 (fax)
email: info@ensuretech.com
Copyright 2001 Ensure Technologies. All rights reserved.